This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

GCS-100 in Combination with R-ICE in Relapsed or Refractory DLBCL

  • Research type

    Research Study

  • Full title

    A Phase 2 Study of GCS-100 in Combination with Chemo-immunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Protocol Number: PR-CS011

  • Contact name

    Rebecca Auer

  • Contact email

  • Sponsor organisation

    Prospect Therapeutics, Inc.

  • Eudract number


  • ISRCTN Number


  • Identifier


  • REC name

    London - Central Research Ethics Committee

  • REC reference


  • Date of REC Opinion

    6 Oct 2008

  • REC opinion

    Further Information Favourable Opinion